Multivariate prediction of the probability of recurrence in patients with carcinoma of the parotid gland

Cancer

Volumn 109, Issue 10, 2007, Pages 2043-2051

  Carrillo, José F ^a,c   Vázquez, Rafael ^a   Ramírez Ortega, Margarita C ^b   Cano, Ana ^a   Ochoa Carrillo, Francisco J ^a   Oñate Ocaña, Luis F ^a  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^b INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^c Departamento 401   (Mexico)

Author keywords

Parotid gland carcinoma; Parotidectomy; Prognostic factors; Recurrence

Indexed keywords

ADENOID CYSTIC CARCINOMA; ADENOSQUAMOUS CARCINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FACIAL NERVE PARALYSIS; FEMALE; HUMAN; KAPLAN MEIER METHOD; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PAROTID GLAND CARCINOMA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; TUMOR DIFFERENTIATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MODELS, STATISTICAL; NEOPLASM RECURRENCE, LOCAL; PAROTID GLAND; PAROTID NEOPLASMS; PROGNOSIS;

EID: 34248353394     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22647     Document Type: Article

References (23)

1. Lima RA, Tavares MR, Dias FL, et al. Clinical prognostic factors in malignant parotid gland tumors. Otolaryngol Head Neck Surg. 2005;133:702-708.
2. Harbo G, Bundgaard T, Pedersen D, Sogaard H, Overgaard J. Prognostic indicators for malignant tumours of the parotid gland. Clin Otolaryngol. 2002;27:512-516.
3. Zbaren P, Schupbach J, Nuyens M, et al. Carcinoma of the parotid gland. Am J Surg. 2003;186:57-62.
4. De Brito Santos IR, Kowalski LP, Cavalcante de Araujo V, Logullo AF, Magrin J. Multivariate analyses of risk factors for neck metastases in surgically treated parotid gland carcinomas. Arch Otolaryngol Head Neck Surg. 2001;127:56-60.
5. Van der Poorten VL, Balm AJM, Hilgers FJ, et al. The development of a prognostic score for patients with parotid carcinoma. Cancer. 1999;85:2057-2067.
6. Van der Poorten VL, Hart AA, van der Laan BF, et al. Prognostic index for patients with parotid carcinoma: external validation using the nationwide 1985-1994 Dutch Head and Neck Oncology Cooperative Group database. Cancer. 2003;97:1453-1463.
7. Bhattcharaya N, Fried MP. Determinants of survival in parotid gland carcinoma: a population-based study. Am J Otolaryngol. 2005;26:39-44.
8. Hocwald E, Korkmaz H, Yoo GH, et al. Prognostic factors in major salivary gland cancer. Layngoscope. 2001;111:1434-1439.
9. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual. 6th ed. New York: Springer-Verlag; 2002.
10. Evenson JW, Auclair P, Gnepp DR, et al. In: Barnes L, Eveson JW, Reichart P, Sidransky D, eds. Pathology and genetics of head and neck tumors. World Health Organization Classification of Tumours. Lyon: IARC Press; 2005:209-281.
11. Luukkaa H, Pekka K, Leivo I, et al. Salivary gland cancer in Finland 1991-1996: an evaluation of 237 cases. Acta Otolaryngol. 2005;125:207-214.
12. Terhaard CHJ, Lubsen H, Van der Tweel I, et al. Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases and overall survival: results of the Dutch Head and Neck Oncology Cooperative Group. Head Neck. 2004;26:681-693.
13. Gallo O, Franchi A, Bottai GV, Fini-Storchi I, Tesi G, Boddi V. Risk factors for distant metastases in parotid gland carcinoma. Cancer. 1997;80:844-851.
14. Therkildsen MH, Christensen M, Andersen LJ, Schiodt T, Hansen HS. Salivary gland carcinomas. Prognostic factors. Acta Oncol. 1998;37:701-713.
15. Nouraei SAR, Hope KL, Kelly CG, McLean NR, Soames JV. Carcinoma ex-benign pleomorphic adenoma of the parotid gland. Plast Recensir Surg. 2005;116:1206-1213.
16. Li J, Wang BY, Nelson M, et al. Salivary gland adenocarcinoma, not otherwise specified. A collection of orphans. Arch Pathol Lab Med. 2004;128:1385-1394.
17. Stennert E, Kisner D, Jungehuelsing M, et al. High incidence of lymph node metastases in major salivary gland cancer. Arch Otolaryngol Head Neck Surg. 2003;129:720-723.
18. Mendenhall WM, Morris CG, Amdur RJ, Werning JW, Villaret DB. Radiotherapy alone or combined with surgery for salivary gland carcinoma. Cancer. 2005;103:2544-2550.
19. Godballe C, Schultz JH, Krogdhal A, Moller-Grontved A, Johanssen J. Parotid carcinoma: impact of clinical factors in prognosis in a histologically revised series. Laryngoscope. 2003;113:1411-1417.
20. Onate-Ocana LF, Cortes-Cardenas SA, Aiello-Crocifoglio V, Mondragon-Sanchez R, Ruiz-Molina JM. Preoperative multivariate prediction of morbidity after gastrectomy for adenocarcinoma. Ann Surg Oncol. 2000;7:281-288.
21. Magnano M, Gervasio CF, Cravero L, et al. Treatment of malignant neoplasms of the parotid gland. Otolaryngol Head Neck Surg. 1999;121:627-632.
22. Brandwein M, Ferlito A, Bradley PJ, Hille JJ, Rinaldo A. Diagnosis and classification of salivary gland neoplasms: pathologic challenges and relevance to clinical outcomes. Acta Otolaryngol. 2002;122:758-764.
23. Dodd RL, Slevin NJ. Salivary gland adenoid cystic carcinoma. A review of chemotherapy and molecular therapies. Oral Oncol. 2006;42:759-769.